Centre for Health Management and Policy Research, School of Health Care Management, Cheeloo College of Medicine, Shandong University, Wenhua Xi Rd 44, Jinan, 250012, Shandong Province, People's Republic of China.
NHC Key Lab of Health Economics and Policy Research, Shandong University, Jinan, 250012, People's Republic of China.
Health Qual Life Outcomes. 2020 Dec 11;18(1):385. doi: 10.1186/s12955-020-01598-4.
Hypertension is a growing public health problem in China; however, little is known about health-related quality of life (HRQoL) especially health state utility (HSU) of patients with hypertension in rural China. This study aimed to examine the HSU as measured by SF-6D and to investigate its associated factors among middle and old aged patients with hypertension in rural China.
Data were collected from twelve villages in Shandong Province in 2016. SF-36 was administrated to measure HRQoL of middle and old aged patients with hypertension and was got to the SF-6D values using Hong Kong's tariff. Descriptive analyses, such as demographic characteristics, socio-economic status, and utility, were stratified by hypertension classification. Multiple linear regression models were applied to assess the associated factors of HSU.
A total of 933 (response rate:86.4%) middle and old aged patients (69.1 ± 8.2 years) with hypertension participated in the study. 39.4% of participants were male; 44.2% had stage I hypertension; 26.4% had stage II and above. The mean score of SF-6D utility score was 0.743 (SD: 0.14, range: 0.32-1.00, median: 0.756, Interquartile range:0.634-0.859). Being female (β = -0.046), having two or more comorbidities (2 vs. 1 β = -0.066; > 3 vs. 1 β = -0.098) and the health expenditure higher than 2000 RMB (2000-3999 vs.< 2000 β = -0.042; 4000-5999 vs. < 2000 β = -0.046; > 6000 vs. < 2000 β = -0.071) were significantly associated with lower SF-6D overall score; while being farmer (β = 0.032), having high household income (10,000-14,999 vs. < 5000 β = 0.045; > 15,000 vs. < 5000 β = 0.064) and having stage I and above hypertension (stage I vs. Normotensive β = 0.047; stage II vs. Normotensive β = 0.079; stage III vs. Normotensive β = 0.095) were significantly associated with higher SF-6D overall score.
SF-6D was capable to measure quality of life middle and old aged patients with hypertension in China. And multiple factors were demonstrated to be significantly associated with quality of life.
高血压是中国日益严重的公共卫生问题;然而,人们对中国农村高血压患者的健康相关生活质量(HRQoL),尤其是健康状态效用(HSU)知之甚少。本研究旨在评估中国农村中老年高血压患者的 HSU,使用 SF-6D 进行测量,并探讨其相关因素。
2016 年,在山东省的 12 个村庄收集数据。使用 SF-36 评估中老年高血压患者的 HRQoL,并使用香港关税将其转换为 SF-6D 值。按高血压分类对人口统计学特征、社会经济状况和效用进行分层描述性分析。应用多元线性回归模型评估 HSU 的相关因素。
共有 933 名(应答率:86.4%)中老年高血压患者(69.1±8.2 岁)参加了这项研究。39.4%的参与者为男性;44.2%患有 1 期高血压;26.4%患有 2 期及以上高血压。SF-6D 效用评分的平均得分为 0.743(SD:0.14,范围:0.32-1.00,中位数:0.756,四分位距:0.634-0.859)。女性(β=-0.046)、患有两种或两种以上合并症(2 种 vs. 1 种β=-0.066;>3 种 vs. 1 种β=-0.098)和医疗支出高于 2000 元人民币(2000-3999 元 vs. <2000 元β=-0.042;4000-5999 元 vs. <2000 元β=-0.046;>6000 元 vs. <2000 元β=-0.071)与 SF-6D 总分较低显著相关;而农民(β=0.032)、高家庭收入(10000-14999 元 vs. <5000 元β=0.045;>15000 元 vs. <5000 元β=0.064)和患有 1 期及以上高血压(1 期 vs. 血压正常β=0.047;2 期 vs. 血压正常β=0.079;3 期 vs. 血压正常β=0.095)与 SF-6D 总分较高显著相关。
SF-6D 能够测量中国中老年高血压患者的生活质量。并且多个因素与生活质量显著相关。